News

Filter

Current filters:

Women's Health

51 to 60 of 96511 results

European Commission abandons plan to transfer control of pharma products to Industry Commissioner

European Commission abandons plan to transfer control of pharma products to Industry Commissioner

14-10-2014

Jean-Claude Juncker, President-elect of the European Commission, has backtracked on his decision to return…

Clinical researchEuropePharmaceuticalPoliticsRegulation

Johnson & Johnson third-qtr results beat analysts’ expectations

14-10-2014

US health care giant Johnsons & Johnson, the first in the sector to report third-quarter 2014 financial…

FinancialJohnson & JohnsonPharmaceutical

Increase in women appointed to life science boards, but their talent needs to be better managed

Increase in women appointed to life science boards, but their talent needs to be better managed

14-10-2014

Although life science company boards are recruiting more women, a lack of managing their talent during…

BoardroomBusinessCorporate governanceManagementPharmaceutical

Astellas links with Harvard to discover new ophthalmic agents

14-10-2014

Japanese drug major Astellas Pharma has entered into a research collaboration with an investigator at…

Astellas PharmaLicensingOphthalmicsPharmaceuticalResearch

EXPERT VIEW: Ethnobridging and the Asian market

EXPERT VIEW: Ethnobridging and the Asian market

14-10-2014

Financial and competitive pressures mean that multinational pharmaceutical companies are constantly looking…

Asia-PacificChinaParexel InternationalPharmaceuticalResearch

Call for India’s Prime Minister to restore drug price caps

14-10-2014

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program,…

IndiaPatentsPharmaceuticalPoliticsPricing

Netherlands Pharma market growth held back by govt generics policy

14-10-2014

The Netherlands’ pharmaceutical market value will rise slowly from around $6.7 billion in 2014 to $7.2…

FinancialGenericsHealthcareMarkets & MarketingNetherlands

Novartis is fined by Indian pricing authority over Voveran

Novartis is fined by Indian pricing authority over Voveran

14-10-2014

Swiss pharma major Novartis has received a penalty charge of 3 billion rupees from the Indian National…

AnalgesiadiclofenacIndiaLegalNovartisPharmaceutical

51 to 60 of 96511 results

Parexel

Parexel

Back to top